1704063-55-7

Basic information

• Product Name: (3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid
• Synonyms: (3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid
• CAS NO: 1704063-55-7
• Molecular Formula: C14H23BN2O3
• Molecular Weight: 278.15502
• Product Categories: Boronate Ester;Boronic Acid;Potassium Trifluoroborate
• Mol File: 1704063-55-7.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid(1704063-55-7)
• EPA Substance Registry System: (3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid(1704063-55-7)

Safety Data

• Hazardous Substances Data: 1704063-55-7(Hazardous Substances Data)

Usage

Description

(3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid is a boronic acid derivative with the molecular formula C17H26BNO3. It contains a piperazine moiety, which makes it potentially useful in medicinal and pharmaceutical applications. (3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid is known for its ability to form reversible covalent complexes with diols, a property that has been widely utilized in the development of protease inhibitors and other pharmaceuticals.

Uses

Used in Pharmaceutical Industry:
(3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid is used as a potential protease inhibitor due to its ability to form reversible covalent complexes with diols. Its specific structure suggests that it may have applications in the development of pharmaceuticals targeting proteases, which are enzymes that play a crucial role in various biological processes and diseases.
Used in Drug Development:
(3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid is used as a compound in drug development for its potential to be incorporated into new pharmaceuticals. The presence of the piperazine moiety and its ability to form reversible covalent complexes with diols make it a promising candidate for the creation of novel therapeutic agents.
Further research and testing would be needed to fully understand the potential uses and properties of (3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid, as its specific applications and efficacy in various industries are not yet fully established.